Lombard Odier Asset Management (Europe) LTD Gilead Sciences, Inc. Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $11,649 - $13,211	-159 Reduced 0.81%	19,432 $1.57 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $713,447 - $778,384	-9,649 Reduced 33.0%	19,591 $1.47 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $880,347 - $1 Million	-11,582 Reduced 28.37%	29,240 $2.25 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $275,068 - $313,388	-3,558 Reduced 8.02%	40,822 $3.39 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $199,361 - $286,214	-3,199 Reduced 6.72%	44,380 $3.81 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $158,912 - $181,518	-2,669 Reduced 5.31%	47,579 $2.94 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $519,710 - $585,350	9,004 Added 21.83%	50,248 $3.11 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $494,984 - $620,268	8,546 Added 26.14%	41,244 $2.45 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $2.12 Million - $2.41 Million	32,698 New	32,698 $2.37 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $918,180 - $1.05 Million	-15,303 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $223,880 - $255,101	3,952 Added 34.82%	15,303 $873,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $148,057 - $189,640	-2,364 Reduced 17.24%	11,351 $849,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $26,604 - $29,833	430 Added 3.24%	13,715 $927,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $27,963 - $32,618	431 Added 3.35%	13,285 $941,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $123,318 - $150,338	-1,693 Reduced 11.64%	12,854 $969,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $1.04 Million - $1.21 Million	14,547	14,547 $1.04 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account